Chemistry and pharmacology of vascular protectants: A novel approach to the treatment of atherosclerosis and coronary artery disease

American Journal of Cardiology

Volumn 91, Issue 3 SUPPL., 2003, Pages 34-40

  Wasserman, Martin A ^a   Sundell, Cynthia L ^a   Kunsch, Charles ^a   Edwards, David ^a   Meng, Charles Q ^a   Medford, Russell M ^a  

^a AtheroGenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHEMOATTRACTANT; LOW DENSITY LIPOPROTEIN; PROBUCOL SUCCINATE; PROTECTIVE AGENT; PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOTECHNOLOGY; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL;

EID: 0037421506     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03148-X     Document Type: Conference Paper

References (16)

1. Medford R.M. Antioxidants and endothelial expression of VCAM-1 a molecular paradigm for atherosclerosis . Gallo L.L. Cardiovascular Disease 2. 1995;121-127 Plenum Press, New York.
2. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 85:1999;753-766.
3. Marui N., Offerman M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 92:1993;1866-1874.
4. Khan B.V., Parthasarathy S.S., Alexander R.W., Medford R.M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 95:1995;1262-1270.
5. Ahmad M., Marui N., Alexander R.W., Medford R.M. Cell type-specific transcription of the VCAM-1 promoter through an NF-κB enhancer motif. J Biol Chem. 270:1995;8976-8983.
6. De Keulenaer G.W., Ushio-Fukai M., Yin Q., Chung A.B., Lyons P.R., Ishizaka N., Rengarajan K., Taylor W.R., Alexander R.W., Griendling K.K. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscles. Arterioscler Thromb Vasc Biol. 20:2000;385-391.
7. Tang R.B., Chen S.J., Soong W.J., Chung R.L. Circulating adhesion molecules in sera of asthmatic children. Pediatr Pulmonol. 33:2002;249-254.
8. Papayianni A., Alexopoulos E., Giamalis P., Gionanlis L., Belechri A.M., Koukoudis P., Memmos D. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients association with inflammation, dyslipidaemia, and vascular events . Nephrol Dial Transplant. 17:2002;435-441.
9. El M., Ashour S., Moustafa H., Ahmed I. Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol. 29:2002;57-61.
10. Rohde L.E., Lee R.T., Rivero J., Jamacochian M., Arroyo L.H., Briggs W., Rifai N., Libby P., Creager M.A., Ridker P.M. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 18:1998;1765-1770.
11. Peter K., Weirich U., Nordt T.K., Ruef J., Bode C. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis. Thromb Haemost. 82:(suppl 1):1999;38-43.
12. Remskar M., Li H., Chyu K.Y., Shah P.K., Cercek B. Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ Res. 88:2001;390-394.
13. Pfuetze K.D., Dujovne C.A. Probucol. Curr Atheroscler Rep. 2:2000;47-57.
14. Walldius G., Erikson U., Olsson A.G., Bergstrand L., Hadell K., Johansson J., Kaijser L., Lassvik C., Molgaard J., Nilsson S., et al. The effect of probucol on femoral atherosclerosis the Probucol Quantitative Regression Swedish Trial (PQRST) . Am J Cardiol. 74:1994;875-883.
15. Tardif J.C., Cote G., Lesperance J., Bourassa M., Lambert J., Doucet S., Bilodeau L., Nattel S., de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 337:1997;365-372.
16. Rodes J., Cote G., Lesperance J., Bourassa M.G., Doucet S., Bilodeau L., Bertrand O.F., Harel F., Gallo R., Tardif J.C. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation. 97:1998;429-436.